Aducanumab: A Deep Dive into BIIB037 and its Impact The drug, originally known as BIIB037, represents a complex attempt to treat mild Alzheimer's condition. Developed by Biogen, aducanumab functions by removing amyloid https://larissalypw532652.blognody.com/49748572/text